• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Recent Advances in the Study of Methyl 4-Acetyl-5-Methyl-1,2-Oxazole-3-Carboxylate (CAS: 104149-61-3)

Methyl 4-acetyl-5-methyl-1,2-oxazole-3-carboxylate (CAS: 104149-61-3) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile applications in drug discovery and development. Recent studies have explored its potential as a key intermediate in the synthesis of bioactive molecules, particularly in the design of novel antimicrobial and anti-inflammatory agents. This research brief aims to summarize the latest findings related to this compound, highlighting its chemical properties, synthetic pathways, and biological activities.

One of the most notable advancements in the study of methyl 4-acetyl-5-methyl-1,2-oxazole-3-carboxylate is its role in the synthesis of oxazole-based derivatives with enhanced pharmacological profiles. Researchers have demonstrated that this compound serves as a crucial building block for the development of inhibitors targeting specific enzymes involved in inflammatory pathways. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported the successful use of this compound in the synthesis of potent cyclooxygenase-2 (COX-2) inhibitors, which exhibited significant anti-inflammatory activity in preclinical models.

In addition to its anti-inflammatory potential, methyl 4-acetyl-5-methyl-1,2-oxazole-3-carboxylate has also been investigated for its antimicrobial properties. A recent study in Bioorganic & Medicinal Chemistry Letters highlighted its utility in the design of novel oxazole-containing antibiotics. The study revealed that derivatives of this compound displayed broad-spectrum activity against both Gram-positive and Gram-negative bacteria, with minimal cytotoxicity toward mammalian cells. These findings underscore the compound's potential as a scaffold for developing next-generation antimicrobial agents.

The synthetic accessibility of methyl 4-acetyl-5-methyl-1,2-oxazole-3-carboxylate has also been a focus of recent research. Advances in green chemistry have led to the development of more efficient and environmentally friendly synthetic routes for this compound. For example, a 2022 study in Organic Process Research & Development described a solvent-free, catalyst-free method for its synthesis, which not only improved yield but also reduced waste generation. Such innovations are critical for scaling up production while adhering to sustainable practices.

Despite these promising developments, challenges remain in the optimization of methyl 4-acetyl-5-methyl-1,2-oxazole-3-carboxylate-based therapeutics. Issues such as bioavailability, metabolic stability, and selectivity need to be addressed to translate preclinical findings into clinical applications. Future research directions may include structure-activity relationship (SAR) studies to refine the compound's pharmacological properties and the exploration of its potential in combination therapies.

In conclusion, methyl 4-acetyl-5-methyl-1,2-oxazole-3-carboxylate (CAS: 104149-61-3) represents a valuable scaffold in medicinal chemistry, with demonstrated applications in anti-inflammatory and antimicrobial drug development. Continued research into its synthetic pathways and biological activities will likely yield further insights, paving the way for innovative therapeutic solutions. This brief underscores the importance of interdisciplinary collaboration in advancing the field of chemical biology and highlights the compound's potential to address unmet medical needs.

• 15911-11-2(Ethyl 4-acetyl-5-methylisoxazole-3-carboxylate)
• 866002-72-4(Ethanone,1-[3-(hydroxymethyl)-5-methyl-4-isoxazolyl]-)
• 160850-61-3(3-Isoxazolecarboxylicacid, 4,5-dimethyl-, methyl ester)
• 160850-62-4(Ethyl 4,5-Dimethylisoxazole-3-carboxylate)
• 160850-63-5(3-Isoxazolecarboxylicacid, 5-ethyl-4-methyl-, methyl ester)
• 198135-28-3(ethyl-methyl-5-methyl-3,4-isoxazole dicarboxylate)
• 160850-64-6(3-Isoxazolecarboxylic acid, 4-ethyl-5-methyl-, ethyl ester)
• 502135-04-8(ethyl 4-(2-ethoxy-2-oxoacetyl)-5-methylisoxazole-3-carboxylate)
• 185333-60-2(Ethyl 4-benzoyl-5-(propan-2-yl)-1,2-oxazole-3-carboxylate)
• 17335-06-7(3-Isoxazolecarboxylicacid, 4-benzoyl-5-methyl-, ethyl ester)